Lancet. 1978 Sep 2;2(8088):492-4.

Prevention of acute porphyric attacks by intravenous haematin.

Lamon JM, Frykholm BC, Bennett M, Tschudy DP.

Abstract

A thirty-three-year-old female with acute intermittent porphyria (A.I.P.) was having regular attacks of the disease with her menstrual periods. During several of these attacks she received intravenous haematin, which was followed by chemical and clinical remissions. Hormones failed to prevent the regular attacks, which were completely prevented by 200 mg of haematin, given approximately once a week for six months. There were no changes in menstruation. The monthly attacks recurred on withdrawal of haematin.

PMID:: 79864; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Medical

Supplemental Content

Save items

Related citations in PubMed

Hematin treatment of acute porphyria. Early remission of an almost fatal relapse. [JAMA. 1976]
Hematin treatment of acute porphyria. Early remission of an almost fatal relapse.
Peterson A, Bossenmaier I, Cardinal R, Watson CJ. JAMA. 1976 Feb 2; 235(5):520-2.
Haematin therapy and leucocyte delta-aminolevulinic-acid-synthase activity in prolonged attack of acute porphyria. [Lancet. 1979]
Haematin therapy and leucocyte delta-aminolevulinic-acid-synthase activity in prolonged attack of acute porphyria.
McColl KE, Thompson GT, Moore MR, Goldberg A. Lancet. 1979 Jan 20; 1(8108):133-4.
[Hematin treatment of acute intermittent porphyria. A case report (author's transl)]. [Rev Bras Pesqui Med Biol. 1979]
[Hematin treatment of acute intermittent porphyria. A case report (author's transl)].
Marchiori PE, de Assis JL, Scaff M, Do Serro-Azul LG, Moraes EC, Bacheschi LA, Yassuda N. Rev Bras Pesqui Med Biol. 1979 Sep; 12(4-5):325-33.
Review Acute intermittent porphyria: pathophysiology and treatment. [Pharmacotherapy. 1984]
Review Acute intermittent porphyria: pathophysiology and treatment.
Khanderia U, Bhattacharya A. Pharmacotherapy. 1984 May-Jun; 4(3):144-50.
Review [Treatment of acute porphyrias. The importance of follow-up of patients and carriers]. [Orv Hetil. 2003]
Review [Treatment of acute porphyrias. The importance of follow-up of patients and carriers].
Tasnádi G, Bor M, Pusztai A. Orv Hetil. 2003 May 11; 144(19):933-8.

See reviews... See all...

Cited by 2 PubMed Central articles

Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic target. [Am J Physiol Gastrointest Live...]
Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic target.
Habtezion A, Kwan R, Yang AL, Morgan ME, Akhtar E, Wanaski SP, Collins SD, Butcher EC, Kamal A, Omary MB. Am J Physiol Gastrointest Liver Physiol. 2011 Jan; 300(1):G12-20. Epub 2010 Oct 21.
Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells. [J Clin Invest. 1994]
Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells.
Cable EE, Pepe JA, Karamitsios NC, Lambrecht RW, Bonkovsky HL. J Clin Invest. 1994 Aug; 94(2):649-54.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prevention of acute porphyric attacks by intravenous haematin.
Prevention of acute porphyric attacks by intravenous haematin.
Lancet. 1978 Sep 2 ;2(8088):492-4.

PubMed
Computer-assisted shock-reinforced Y-maze training: a method for studying spatia...
Computer-assisted shock-reinforced Y-maze training: a method for studying spatial alternation behaviour.
Neuroreport. 1994 Oct 27 ;5(16):2061-4.

PubMed
Homocystinuria. Evidence for three distinct classes of cystathionine beta-syntha...
Homocystinuria. Evidence for three distinct classes of cystathionine beta-synthase mutants in cultured fibroblasts.
J Clin Invest. 1978 Mar ;61(3):645-53.

PubMed
Therapeutic trial of plasmapheresis in Refsum disease and in Fabry disease.
Therapeutic trial of plasmapheresis in Refsum disease and in Fabry disease.
Birth Defects Orig Artic Ser. 1980 ;16(1):491-7.

PubMed
Circulating immune complexes in mixed connective tissue disease.
Circulating immune complexes in mixed connective tissue disease.
Arthritis Rheum. 1979 May ;22(5):484-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Prevention of acute porphyric attacks by intravenous haematin.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information